KDOQI (Kidney Disease Outcomes Quality Initiative)


NKF KDOQI GUIDELINES

Executive Summaries | Anemia | Hemodialysis | Peritoneal Dialysis |
Vascular Access | Nutrition | CKD 2002 | Dyslipidemias | Bone Metabolism | Hypertension and Antihypertensive Agents | Cardiovascular Disease in Dialysis Patients | History of K/DOQ | Pediatric Bone |

KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Children With Chronic Kidney Disease


Figures

Figure 1.

Relationship between Serum iPTH Levels and CCR
Figure 2. Summary ROC Analysis of Erosions on X-Ray as Diagnostic for Osteitis Fibrosa
Figure 3.

Summary ROC Analysis of Intact PTH for Diagnosis of High-Turnover Bone Disease

Figure 4. Summary ROC Analysis of Intact PTH for Diagnosis of Low-Turnover Bone Disease
Figure 5. Meta-Analysis of Size of Effect on Serum Phosphorus Levels of Calcium Acetate versus Calcium Carbonate
Figure 6. Meta-Analysis of Size of Hypercalcemic Effect of Calcium Carbonate versus Other Phosphate Binders
Figure 7.

Meta-Analysis of Oral versus Intravenous Calcitriol on PTH Suppression

Figure 8. Individual Study and Summary Effect Sizes for the Effect of DFO Therapy on Bone Formation Rate
Figure 9. Individual Study and Summary Effect Sizes for the Effect of DFO Therapy on Bone Surface Aluminum Stain